PDB4 THE HEALTH-ECONOMIC IMPLICATIONS OF THE 'IRBESARTAN IN DIABETIC NEPHROPATHY TRIAL' (IDNT) IN FRANCE AND BELGIUM
Abstract
Authors
AJ Palmer L Annemans S Roze M Lamotte C Guilhaume S Gabriel P Carita R Chen T Simon R Rodby DJ Cordonnier